Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amnon Peled

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
JCI Insight|June 22, 2023
CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitisRaanan Greenman, Michal Segal-Salto, Neta Barashi, et al.
The Journal of Clinical Investigation|June 10, 2014
Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftmentMitchell E Horwitz, Nelson J Chao, David A Rizzieri, et al.
Nature Medicine|May 27, 2020
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trialBruno Bockorny, Valerya Semenisty, Teresa Macarulla, et al.
Cancer|December 3, 2020
BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a studyGautam Borthakur, Yishai Ofran, Martin S Tallman, et al.
Journal of Hepatology|August 21, 2022
Combined hepatocellular-cholangiocarcinoma derives from liver progenitor cells and depends on senescence and IL-6 trans-signalingNofar Rosenberg, Matthias Van Haele, Tali Lanton, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
JCI Insight|June 22, 2023
CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitisRaanan Greenman, Michal Segal-Salto, Neta Barashi, et al.
The Journal of Clinical Investigation|June 10, 2014
Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftmentMitchell E Horwitz, Nelson J Chao, David A Rizzieri, et al.
Nature Medicine|May 27, 2020
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trialBruno Bockorny, Valerya Semenisty, Teresa Macarulla, et al.
Cancer|December 3, 2020
BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a studyGautam Borthakur, Yishai Ofran, Martin S Tallman, et al.
Journal of Hepatology|August 21, 2022
Combined hepatocellular-cholangiocarcinoma derives from liver progenitor cells and depends on senescence and IL-6 trans-signalingNofar Rosenberg, Matthias Van Haele, Tali Lanton, et al.
Pageof 9